Annual report pursuant to Section 13 and 15(d)

Discontinued Operations

v3.23.1
Discontinued Operations
12 Months Ended
Dec. 31, 2022
Discontinued Operations [Abstract]  
Discontinued Operations NOTE 7– DISCONTINUED OPERATIONS

Pursuant to the merger agreement, the Company is working to divest its legacy operations and operating assets. The Company is actively pursuing the sale of its JDL and Ecessa businesses and has met the criteria to report the operations of these businesses as discontinued operations beginning in the fourth quarter of 2022.

The assets and liabilities of the discontinued operations that are classified as held for sale are as follows:

December 31, 2022

December 31, 2021

Trade accounts receivable, net

$

752,420

$

Inventories, net

145,808

Other current assets

255,871

Total current assets

$

1,154,099

$

Property, plant, and equipment, net

$

69,270

$

Right of use asset

46,025

Intangible assets

2,110,550

Goodwill

45,688

Total noncurrent assets

$

2,271,533

$

Total assets held for sale

$

3,425,632

$

Accounts payable

$

381,992

$

Accrued compensation and benefits

184,585

Operating lease liability

50,170

Other accrued liabilities

10,727

Deferred revenue

533,685

Total current liabilities

$

1,161,159

$

Deferred revenue

$

250,875

$

Total noncurrent liabilities

$

250,875

$

Total liabilities held for sale

$

1,412,034

$

The financial results of the discontinued operations are as follows:

Year Ended December 31

2022

2021

Sales

$

5,291,492

$

Cost of sales

3,798,807

Selling, general and administrative expenses

1,295,120

Amortization expense

496,450

Transaction costs

53,361

Goodwill impairment loss

6,718,612

Operating loss before income taxes

(7,070,858)

Income tax expense

3,326

Net loss from discontinued operations

$

(7,074,184)

$

Due to CVR Representative’s approval of the planned sale of JDL and Ecessa and its discontinued operations assessment in the fourth quarter of 2022, the Company determined there was a triggering event that warranted an interim impairment assessment. Based on the quantitative assessment, the Company recorded an impairment loss of $6,718,612.